Aurum Biosciences Attending and Presenting at Biotrinity 2017

Aurum Biosciences is attending and presenting a company showcase at this years Biotrinity event in London, which is being held today and tomorrow (9th and 10th May 2017). Aurum will be presenting information on its current development program and its plans to develop its lead product ABL-101 into a truly multi-market disruptive technology.

Biotrinity is one of Europe’s leading bio-partnering and investment conferences, and the largest of its type in the UK. Details of the program along with information on the timing of Aurum’s showcase presentation can be found here.